Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000930413-15-001217
Filing Date
2015-03-13
Accepted
2015-03-13 16:19:13
Documents
2

Document Format Files

Seq Description Document Type Size
1 c80645_sc13g.htm SC 13G 67060
2 c80645_ex1.htm EX-1 3694
  Complete submission text file 0000930413-15-001217.txt   72411
Mailing Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST, SUITE 100 SEATTLE WA 98102 (206) 504-7278
TAPIMMUNE INC (Subject) CIK: 0001094038 (see all company filings)

EIN.: 880277072 | State of Incorp.: NV | Fiscal Year End: 0220
Type: SC 13G | Act: 34 | File No.: 005-58217 | Film No.: 15699580
SIC: 2834 Pharmaceutical Preparations

Mailing Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022
Business Address 641 LEXINGTON AVENUE 26TH FLOOR NEW YORK, NY 10022 212.974.3070
Iroquois Capital Management, LLC (Filed by) CIK: 0001481867 (see all company filings)

EIN.: 010786483 | State of Incorp.: DE
Type: SC 13G